Cargando…

High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid

PURPOSE: The objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis. METHODS: Eligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shunde, Ge, Chengguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423154/
https://www.ncbi.nlm.nih.gov/pubmed/37270459
http://dx.doi.org/10.1007/s00432-023-04867-z
_version_ 1785089384059502592
author Wang, Shunde
Ge, Chengguo
author_facet Wang, Shunde
Ge, Chengguo
author_sort Wang, Shunde
collection PubMed
description PURPOSE: The objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis. METHODS: Eligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (SMRs). The proportions of different non-cancer cause of death were calculated and analyzed in different follow-up periods. Multivariate competing risk model was used to analyze the risk factors for death of BC and non-cancer diseases. RESULTS: In total, 240,954 BC patients were included and 106,092 patients experienced death, with 37,205 (35.07%), 13,208 (12.45%) and 55,679 (52.48%) patients experienced BC, other cancer and non-cancer disease-related deaths, respectively. Overall SMR for BC patients who died from non-cancer diseases was 2.42 (95% CI [2.40–2.44]). Cardiovascular diseases were the most common non-cancer cause of death, followed by respiratory diseases, diabetes mellitus, and infectious diseases. Multivariate competing risk analysis identified the following high-risk factors for non-cancer mortality: age > 60 years, male, whites, in situ stage, pathological type of transitional cell carcinoma, not receiving treatment (including surgery, chemotherapy, or radiation), and widowed. CONCLUSIONS: Cardiovascular diseases are the leading non-cancer cause of death in BC patients, followed by respiratory disease, diabetes mellitus and infectious diseases. Physicians should pay attention to the risk of death from these non-cancer diseases. Also, physicians should encourage patients to engage in more proactive self-surveillance and follow up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04867-z.
format Online
Article
Text
id pubmed-10423154
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-104231542023-08-14 High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid Wang, Shunde Ge, Chengguo J Cancer Res Clin Oncol Research PURPOSE: The objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis. METHODS: Eligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (SMRs). The proportions of different non-cancer cause of death were calculated and analyzed in different follow-up periods. Multivariate competing risk model was used to analyze the risk factors for death of BC and non-cancer diseases. RESULTS: In total, 240,954 BC patients were included and 106,092 patients experienced death, with 37,205 (35.07%), 13,208 (12.45%) and 55,679 (52.48%) patients experienced BC, other cancer and non-cancer disease-related deaths, respectively. Overall SMR for BC patients who died from non-cancer diseases was 2.42 (95% CI [2.40–2.44]). Cardiovascular diseases were the most common non-cancer cause of death, followed by respiratory diseases, diabetes mellitus, and infectious diseases. Multivariate competing risk analysis identified the following high-risk factors for non-cancer mortality: age > 60 years, male, whites, in situ stage, pathological type of transitional cell carcinoma, not receiving treatment (including surgery, chemotherapy, or radiation), and widowed. CONCLUSIONS: Cardiovascular diseases are the leading non-cancer cause of death in BC patients, followed by respiratory disease, diabetes mellitus and infectious diseases. Physicians should pay attention to the risk of death from these non-cancer diseases. Also, physicians should encourage patients to engage in more proactive self-surveillance and follow up. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00432-023-04867-z. Springer Berlin Heidelberg 2023-06-03 2023 /pmc/articles/PMC10423154/ /pubmed/37270459 http://dx.doi.org/10.1007/s00432-023-04867-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
Wang, Shunde
Ge, Chengguo
High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title_full High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title_fullStr High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title_full_unstemmed High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title_short High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid
title_sort high risk of non-cancer mortality in bladder cancer patients: evidence from seer-medicaid
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423154/
https://www.ncbi.nlm.nih.gov/pubmed/37270459
http://dx.doi.org/10.1007/s00432-023-04867-z
work_keys_str_mv AT wangshunde highriskofnoncancermortalityinbladdercancerpatientsevidencefromseermedicaid
AT gechengguo highriskofnoncancermortalityinbladdercancerpatientsevidencefromseermedicaid